Semen Baturaja Persero Tbk (SMBR)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 117.00 |
|---|---|
| 52-week range | 116.00 – 313.52 |
| Return, 1 month / 3 months | −32.0% / −29.5% |
| Return, 1 year / 3 years | −54.1% / −65.9% |
| Trend | Below its 200-day average |
| RSI (14) | 19 |
| Volatility (1 year) | 48.8% |
| Worst drawdown (1 year) | -61.5% |
| Average daily value traded | 1,575.93M IDR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Semen Baturaja Persero Tbk is an Indonesian cement manufacturer based in Baturaja, South Sumatra. The company produces and sells cement and related building materials, serving construction companies, distributors and retail customers across Indonesia. Its operations cover the mining of raw materials, cement production and the distribution of bagged and bulk cement to customers in Sumatra and other parts of the country.
The shares are listed on the Jakarta Exchange in Indonesia under the code SMBR, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Semen Baturaja Persero Tbk (SMBR) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 117.00 on 19 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 696 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 54.1% and over the last three months it fell 29.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -40.8% | ||
| From 52-week high | -61.5% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -29.5% | ||
| 6-month return | -45.2% | ||
| 12-month return, skipping the last month | -32.5% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -61.5% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,575.93M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −22.0% |
|---|---|
| 1 month | −32.0% |
| 3 months | −29.5% |
| 6 months | −45.2% |
| 1 year | −54.1% |
| 3 years | −65.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 162.56 / 197.62 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | IDR 3.4619 |
| 11 Jun 2025 | IDR 2.6026 |
| 7 Jun 2024 | IDR 2.4479 |
| 17 May 2023 | IDR 1.9094 |
| 14 Aug 2020 | IDR 0.6201 |
| 27 May 2019 | IDR 1.9100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.